Clinical Trial Update: Pediatric Low Grade Glioma - MEKinhibitor TRIal vs Chemotherapy [Phase 2]

View source ↗

Summary

A Phase 2 pediatric trial is evaluating a MEK inhibitor versus chemotherapy for pediatric low-grade gliomas, including Grade 1 glioma and mixed glioneuronal tum…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Low-grade Glioma
• Mixed Glioneuronal Tumors
• Pleomorphic Xanthoastrocytoma

Drugs mentioned

• MEK inhibitor (study drug)

Snippet

Sponsor: University Hospital, Strasbourg, France | Conditions: Grade 1 Glioma, Mixed Glio-neuronal Tumors | Phase 2 | Status: RECRUITING